Insight Pharma Reports Market Research Reports

Highlights of this Report Include: Approvals of checkpoint inhibitors Biomarkers for checkpoint inhibitor treatments Approved and clinical-stage immunotherapy biologics other than checkpoint inhi...

The field of Human Microbiome research and development is apparently one of the most popular hubs of the biotechnology industry. While the Human Microbiome Project, MetaHIT and other huge studies of human microbiota, have garnered a lot of attenti...

Recombinant antibodies have been the shining jewels in the firmament of the pharma industry for almost the last two decades. They have returned billions of dollars in sales, and if their performance has not been the unalloyed triumph that was fore...

Insight Pharma Reports’ Gene Therapy: Moving Toward Commercialization”, outlines the progress of the gene therapy field since its inception in the 1970s, with a special focus on clinical-stage gene therapy programs tha...

New to Insight Pharma Reports is Digital Pathology Insights:  Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks. This report delves into the rapidly evolving field of digital pathology, briefly reviewing the und...

The newly published Insight Pharma Reports, Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable, and Lean Biomanufacturing System Report, focus on the need for a more reactive and dynamic biomanufacturing approach than is the cur...

Available to Insight Pharma Reports is Ocular Disorders: Rising Therapeutics, Technologies, and Devices Report. This report begins with outlining Age-related macular degeneration (both wet and dry) and delving into Anti-VEGF therapies in chapter 2...

New to Insight Pharma Reports is Prenatal Diagnostics: Invasive Testing, Noninvasive Testing, and Rising Maternal Screening Methods for Preeclampsia and Preterm Labor. This report discusses improvements in invasive procedures (karyotyping vs. cyto...

OverviewCancer diagnostics based on measuring biomarkers in tissue samples has already in the past decade provided revolutionary advances in diagnosis, prognosis, and therapy selection. A major drawback of the tissue-based ...

OverviewPublished in October, 2014, is Insight Pharma Reports' The Human Microbiome: Biomedical Implications and Birth of a Market. This report covers the evolution of microbiome research and its growth in the commercia...

OverviewThis report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians and patient...

OverviewBiomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers have bee...

Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies covers market research, relevant disease background, and a number of rising technologies available to physicians and clinicians in the cancer and pr...

This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance ...

This report covers the specifics of microRNA (miRNA) as it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding n...